男性脑膜瘤发生的激素因素:病例对照研究
该病例对照研究纳入2003至2021年间在魁北克拉瓦尔大学附属医院诊断的颅内脑膜瘤男性患者(n=288),评估激素暴露与脑膜瘤风险的关联。结果发现5α-还原酶抑制剂使用与脑膜瘤风险升高相关(OR 5.99 [1.99–18.06],p=0.0015),输精管切除术(OR 0.35 [0.18–0.68],p=0.0021)和脱发(OR 0.24 [0.12–0.45],p<0.0001)与风险降低相关,其他激素因素无显著关联。
要点
- 5α-还原酶抑制剂使用与男性脑膜瘤风险升高相关(OR 5.99)。
- 输精管切除术和脱发与脑膜瘤风险降低相关。
- 其他内源性和外源性激素因素未见显著关联。
核心结论
- 5α-还原酶抑制剂使用可能与男性脑膜瘤发生相关,提示孕酮在病理生理中可能发挥作用。
- 输精管切除术和脱发与脑膜瘤风险降低的关联需进一步研究,可能受研究设计偏倚限制。
研究设计与样本
- 病例对照研究,纳入2003年1月1日至2021年1月1日在魁北克拉瓦尔大学附属医院诊断的颅内脑膜瘤男性患者(n=288)。
主要发现
- 5α-还原酶抑制剂使用与脑膜瘤风险升高显著相关(OR 5.99 [1.99–18.06],p=0.0015)。
- 输精管切除术与脑膜瘤风险降低显著相关(OR 0.35 [0.18–0.68],p=0.0021)。
- 脱发与脑膜瘤风险降低显著相关(OR 0.24 [0.12–0.45],p<0.0001)。
- 其他内源性和外源性激素因素与脑膜瘤发生无显著关联。
临床怎么用
- 在评估男性脑膜瘤风险时,应关注5α-还原酶抑制剂的使用史。
- 输精管切除术和脱发与风险降低的关联需谨慎解读,不作为临床决策依据。
局限性
- 输精管切除术和脱发相关发现可能受研究设计偏倚限制。
- 需要更强有力的前瞻性研究来更好理解激素因素对脑膜瘤风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The characterization of meningiomas within the male population, particularly regarding the potential over-representation of hormonal factors, currently lacks precision, emphasizing the need for a comprehensive understanding of risk factors influencing their development or growth. This study aims to delineate the hormonal profiles in males diagnosed with meningiomas and seeks to identify whether specific factors are more prevalent in this population compared to a control group. METHODS: A case-control study was conducted, involving eligible individuals (n = 288) diagnosed with intracranial meningiomas between January 1st, 2003, and January 1st, 2021, at ‘Hôpital de l’Enfant-Jésus CHU-de-Québec – Université Laval’. Hormonal exposure, including 5α-reductase inhibitors, gonadotropin-releasing hormone (GnRH), testosterone, anti-androgens, medication for alopecia and hair loss, spironolactone, and other hormonal comorbidities, was assessed. RESULTS: A statistically significant association was identified between the use of 5α-reductase inhibitors and an increased risk of meningioma in men (OR 5.99 [1.99–18.06], p = 0.0015). Vasectomy (OR 0.35 [0.18–0.68], p = 0.0021) and alopecia (OR 0.24 [0.12–0.45], p = < 0.0001) were associated with a decreased risk of meningioma, while other endogenous and exogenous hormonal factors showed no significant associations with meningioma development. CONCLUSION: The study highlights a potential link between 5α-reductase inhibitor use and meningioma development, suggesting a role for progesterone in the pathophysiology. While the findings related to vasectomy and alopecia warrant further investigation, they are likely limited by study design biases. These results emphasize the need for more robust, prospective studies to better understand the hormonal factors influencing meningioma risk.
引用
- Berthold C, Boudreault A, Simonyan D, et al. Hormonal factors predisposing to the development of meningiomas in men: a case-control study. J Neurooncol. 2025. PMID: 41171375. doi:10.1007/s11060-025-05317-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。